Innate Pharma SA (FRA:IDD)
€ 1.614 0.01 (0.62%) Market Cap: 136.32 Mil Enterprise Value: 80.03 Mil PE Ratio: 0 PB Ratio: 4.66 GF Score: 67/100

Q4 2020 Innate Pharma SA Earnings Call Transcript

Mar 18, 2021 / 01:00PM GMT
Release Date Price: €3.86 (-3.16%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Innate Pharma Full Year 2020 Results Conference Call. (Operator Instructions) I must advise you that this conference is being recorded today, Thursday, 18th of March 2021.

I would now like to hand the conference over to first speaker today, Mr. Mondher Mahjoubi. Thank you. Please go ahead.

Mondher Mahjoubi
Innate Pharma S.A. - Chairman of Executive Board & CEO

Thank you. Good morning, good afternoon and welcome to everyone. This morning, Innate Pharma issued a press release reporting financial results and business updates for the fourth quarter and full year 2020. The press release and today's presentation are available on the IR website -- on the IR section of our website.

Please move to start 2 -- Slide #2. Before we start, I would like to remind you that we will make forward-looking statements regarding the financial outlook in addition to regulatory and product development plans. These statements are subject to risks and uncertainties that may cause actual results to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot